Keywords: |
treatment outcome; clinical feature; preoperative care; pancreatic neoplasms; preoperative evaluation; letter; pancreaticoduodenectomy; biological markers; computer assisted tomography; diagnosis, differential; differential diagnosis; carcinoma, pancreatic ductal; steroid; cost effectiveness analysis; health care cost; prednisolone; immunoglobulin g; diagnostic value; pancreatitis; remission; pancreas adenocarcinoma; autoimmunity; lymphocytic infiltration; autoimmune diseases; immunoglobulin blood level; cost-benefit analysis; immunoglobulin g4; costs and cost analysis; unnecessary procedures; steroid therapy; autoimmune pancreatitis; humans; human; priority journal
|